Clinical Trials Directory

Trials / Sponsors / InSilico Medicine Hong Kong Limited

InSilico Medicine Hong Kong Limited

Industry · 9 registered clinical trials — 6 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingStudy of ISM5939 in Patients With Advanced and/or Metastatic Solid Tumors
Advanced Solid Tumor, Metastatic Solid Tumor, Advanced and/or Metastatic Solid Tumors
Phase 12026-06-30
RecruitingStudy Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA)
Ulcerative Colitis
Phase 22025-12-10
RecruitingStudy of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors
Locally Advanced/Metastatic Solid Tumors
Phase 12025-04-25
RecruitingStudy of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors
Malignant Mesothelioma, Metastatic Malignant Solid Tumor, Advanced Solid Tumor
Phase 12024-12-27
RecruitingStudy Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma
Advanced Solid Tumors, Relapsed/Refractory B-cell Lymphoma
Phase 12024-04-25
RecruitingStudy Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis (IPF)
Phase 22024-02-08
CompletedStudy Evaluating ISM5411 Administered Orally to Healthy Volunteers
Healthy Subjects
Phase 12023-11-08
CompletedStudy Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis (IPF)
Phase 22023-06-19
CompletedA Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy Subjects
Idiopathic Pulmonary Fibrosis
Phase 12022-02-21